Rachel K. King - Net Worth and Insider Trading
Rachel K. King Net Worth
The estimated net worth of Rachel K. King is at least $254,732 dollars as of 2024-11-13. Rachel K. King is the President, CEO of GlycoMimetics Inc and owns about 531,206 shares of GlycoMimetics Inc (GLYC) stock worth over $212,482. Rachel K. King is also the Director of Novavax Inc and owns about 5,000 shares of Novavax Inc (NVAX) stock worth over $42,250. Details can be seen in Rachel K. King's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rachel K. King has not made any transactions after 2021-05-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rachel K. King
Rachel K. King Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rachel K. King owns 2 companies in total, including Novavax Inc (NVAX) , and GlycoMimetics Inc (GLYC) .
Click here to see the complete history of Rachel K. King’s form 4 insider trades.
Insider Ownership Summary of Rachel K. King
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVAX | Novavax Inc | 2021-05-19 | director |
| GLYC | GlycoMimetics Inc | 2020-12-28 | director & President & CEO |
Rachel K. King Latest Holdings Summary
Rachel K. King currently owns a total of 2 stocks. Among these stocks, Rachel K. King owns 531,206 shares of GlycoMimetics Inc (GLYC) as of December 28, 2020, with a value of $212,482 and a weighting of 83.41%. Rachel K. King also owns 5,000 shares of Novavax Inc (NVAX) as of May 19, 2021, with a value of $42,250 and a weighting of 16.59%.
Latest Holdings of Rachel K. King
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GLYC | GlycoMimetics Inc | 2020-12-28 | 531,206 | 0.40 | 212,482 |
| NVAX | Novavax Inc | 2021-05-19 | 5,000 | 8.45 | 42,250 |
Holding Weightings of Rachel K. King
Rachel K. King Form 4 Trading Tracker
According to the SEC Form 4 filings, Rachel K. King has made a total of 1 transactions in GlycoMimetics Inc (GLYC) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in GlycoMimetics Inc is the sale of 84,176 shares on December 28, 2020, which brought Rachel K. King around $329,128.
According to the SEC Form 4 filings, Rachel K. King has made a total of 1 transactions in Novavax Inc (NVAX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Novavax Inc is the acquisition of 700 shares on May 19, 2021, which cost Rachel K. King around $97,748.
Insider Trading History of Rachel K. King
- 1
Rachel K. King Trading Performance
GuruFocus tracks the stock performance after each of Rachel K. King's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rachel K. King is 5.53%. GuruFocus also compares Rachel K. King's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rachel K. King within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rachel K. King's insider trading performs compared to the benchmark.
Performance of Rachel K. King
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.58 | | | | | |
| Relative Return to S&P 500(%) | 4.57 | | | | | |
Rachel K. King Ownership Network
Ownership Network List of Rachel K. King
Ownership Network Relation of Rachel K. King
Rachel K. King Owned Company Details
What does Novavax Inc do?
Who are the key executives at Novavax Inc?
Rachel K. King is the director of Novavax Inc. Other key executives at Novavax Inc include President & R&D Filip Dubovsky , President & R&D Gregory M Glenn , and EVP & Chief Strategy Officer Elaine O'hara .
Novavax Inc (NVAX) Insider Trades Summary
Over the past 18 months, Rachel K. King made no insider transaction in Novavax Inc (NVAX). Other recent insider transactions involving Novavax Inc (NVAX) include a net sale of 61,216 shares made by Filip Dubovsky , and a net sale of 15,000 shares made by James F Young .
In summary, during the past 3 months, insiders sold 0 shares of Novavax Inc (NVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,216 shares of Novavax Inc (NVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 76,216 shares.
Novavax Inc (NVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Novavax Inc Insider Transactions
Rachel K. King Mailing Address
Above is the net worth, insider trading, and ownership report for Rachel K. King. You might contact Rachel K. King via mailing address: C/o Glycomimetics, Inc., 401 Professional Drive, Suite 250, Gaithersburg Md 20879.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
